TPG, a US-based private equity investment firm, has purchased Optum UK, a healthcare technology company, in a transaction valued at approximately $400m. The acquisition grants the firm control over EMIS software, which manages electronic patient records for millions of patients across more than half of England’s general practice clinics.
The deal has prompted significant criticism from medical professionals, lawmakers, and patient advocacy groups who contend that the transfer occurred with insufficient public scrutiny and transparency. Representatives from Doctors’ Association UK emphasized concerns that patient records now rest with a firm prioritizing investor returns rather than patient welfare, and questioned what safeguards exist if TPG later divests the asset. Liberal Democrat health spokesperson Helen Morgan characterized such transactions as being approved “without any scrutiny or protections for patients” and advocated for increased government support of domestic technology companies.
Additional concerns center on TPG’s international healthcare operations. An investigation by the International Consortium of Investigative Journalists earlier in the year examined hospitals in Kenya owned by Evercare, a healthcare entity backed by TPG’s Rise Fund, and reported allegations that certain patients faced substantial medical debt and were required to pledge property as collateral for unpaid bills. TPG disputed these characterizations, stating it has invested more than $100m in Evercare over six years and instituted extensive clinical governance and patient protections.
Anna Marriott, former health policy lead at Oxfam, stated that private equity involvement in NHS health services is expanding faster than regulatory frameworks can accommodate. She asserted that the government bears responsibility for ensuring patient data safety given that NHS patients have no direct voice in such decisions.
Both EMIS and TPG representatives asserted that the ownership change does not alter data protection standards, with statements emphasizing compliance with regulatory obligations and existing security measures. EMIS noted the acquisition was reviewed and approved by the UK government through channels established under the National Security and Investment Act 2021. The Department of Health and Social Care did not provide comment on the transaction.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI